FDI World Dental Federation: Prescribing of dental antibiotics up 22% in England during first year of COVID-19 / Prescriptions of all other antibiotics fell during the same period
mehr
Storys zum Thema Medicale
Anteryon reports clear growth figures in a challenging year.
Eindhoven, The Netherlands (ots/PRNewswire) - Anteryon, a specialist in high-tech optical components, has helped its global customer base turn more ideas into solutions even during the past Covid year. The company reports crystal-clear growth figures and is set to continue growing at a rapid pace. Anteryon creates, develops and produces clear solutions for optical challenges. From its own competence centre, located at ...
mehrHovione invests $170 million in new capacity and capabilities
Milan (ots/PRNewswire) - Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives. The company has been on an expansion track since 2016 in Portugal, Ireland and New Jersey with the aim of continuing to increase its capacity and capabilities to address customer needs. The announcement of a ...
mehrGenomics England; Queen Mary University of London (QMUL)
Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study
London (ots/PRNewswire) - NB: SCIENCE MEDIA BRIEFING TAKING PLACE 14:00 GMT 9TH NOVEMBER 2021 - whole genome sequencing proved to be a better way to diagnose rare diseases than usual genomic testing methods - whole genome sequencing led to new rare disease diagnoses for NHS patients in some cases ending decades-long ...
mehrPfizer tops the CNS Summit Innovation Index
London (ots/PRNewswire) - The fifth annual ranking of digital, R&D and commercial partnership innovation in global pharma The fifth annual CNS Summit Innovation Index, compiled by IDEA Pharma, sees Pfizer top the industry. Released at the CNS Summit in Boston, MA, the CNS Summit Innovation Index examines which drug makers are leveraging innovation in three spheres: clinical development which sets the stage for future ...
mehrSwiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round for Mekonos
Lausanne, Switzerland - San Francisco (ots) - Funding to accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today having invested $4M inMekonos, a biotech company building the future of cell ...
mehr
EPI Health and MC2 Therapeutics Announce Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) now covered on Express Scripts National Preferred Formulary
Charleston, S.c. and Copenhagen, Denmark (ots/PRNewswire) - Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older. EPI Health, LLC, a specialty pharmaceutical company committed to delivering innovative ...
mehrWegovy(TM) Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity
Bagsværd, Denmark (ots/PRNewswire) - - The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy(TM) at 104-weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo - The trial also showed that 77.1% of study participants who received Wegovy(TM) lost at ...
mehrZentiva Advances Pharmaceutical Research Through ORBIS Project
Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...
mehrAbcam; Nautilus Biotechnology, Inc.
As an element of Nautilus' overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam's antibody development technology and expertise
Seattle and Cambridge, England (ots/PRNewswire) - Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a ...
mehrthe International Diabetes Federation
Diabetes is "a pandemic of unprecedented magnitude" now affecting one in 10 adults worldwide, reveals the International Diabetes Federation
Brussels (ots/PRNewswire) - New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living with diabetes worldwide - a rise of 16% (74 ...
mehrPanoramix research project set out to evaluate the risk of chemical mixtures for human health
Brussels (ots/PRNewswire) - Panoramix (Providing risk assessments of complex real-life mixtures for the protection of European citizens and the environment), a 4-year project led by the Technical University of Denmark, focuses on innovative ways for quantifying the risk associated with exposure to chemical mixtures, without animal testing. The project is supported by ...
mehr
World Stroke Day: Global survey reveals only 35% hospitals worldwide provide essential stroke treatment
Geneva (ots/PRNewswire) - On World Stroke Day, 29 October, the World Stroke Organization (WSO) is calling for urgent action after a survey by the WSO and the World Health Organization (WHO) found that only 35% of hospitals worldwide provide essential clot-busting medicine tissue plasminogen activator (tPA), despite ...
mehrRoche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Basel, Switzerland (ots/PRNewswire) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with ...
mehrRoche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Basel (ots) - - Roche, a world leader in integrated Personalised Diabetes Management, and the Zur Rose Group, provider of a European digital healthcare ecosystem, announce their collaboration to improve everyday therapy management and better address the needs of 60 million people living with diabetes in Europe [1] - ...
mehrThe International Osteoporosis Foundation (IOF)
Action for bone health is needed now more than ever, urges IOF
mehrCARB-X FUNDS THE 3RD ROUND OF DEBIOPHARM’S TARGETED ANTIBIOTIC PROGRAM TO COMBAT RESISTANT N. GONORRHOEAE INFECTIONS
Lausanne, Switzerland / Boston, USA (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical ...
mehrSeibersdorf Labor GmbH; Isotopia Molecular Imaging
Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...
mehr
Micreos appoints Matt Regan as CEO of its Pharmaceutical business
The Hague, Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a separate company as per January 2022 to directly access the capital markets. This will help to fund pipeline development to progress its highly ...
mehrNovaliq Receives EU Quality Management Certificate According To New Medical Device Regulation (MDR)
Heidelberg, Germany (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that it has implemented and applies a quality management system in accordance with Annex IX, Chapter I of the EU ...
mehrFresenius Kabi Deutschland GmbH
Fresenius Kabi at ESPEN Virtual Congress 2021: EuroPN Study will provide new clinical data on critical care nutrition
Bad Homburg, Germany (ots/PRNewswire) - Real-world-data on the medical nutrition practice in Intensive Care Units (ICU) for critically ill patients is limited so far. To close this knowledge gap, Fresenius Kabi started EuroPN Study in 2019 in eleven European countries with around 100 participating hospitals[1]. At ...
mehrDEBIOPHARM & DEXA MEDICA LAUNCH TRIPTORELIN COLLABORATION TO BRING NEW HOPE TO WOMEN WITH ENDOMETRIOSIS
Lausanne, Switzerland – Tangerang, Indonesia (ots) - Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, and Dexa Medica, a leading Indonesian pharmaceutical company, today announced the Indonesian launch of triptorelin for the treatment of women with gynecological disorders, ...
mehrNorgine B.V. celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer
Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine), a leading European specialist pharmaceutical company, celebrates its 30th anniversary of continuous innovation in bowel preparations at the United European Gastroenterology (UEG) Week Virtual. Bowel preparations are used in colonoscopy to prevent and diagnose ...
mehrUrine Analysis Enters Golden Era With World's First Hands Free Optical Sensor For The Toilet Targeting Early Detection Of Disease In The Elderly And Even Pregnant Women
Jerusalem (ots/PRNewswire) - Home-based Urinalysis technology innovator, Olive Diagnostics, begins financing round led by the Maccabi Foundation, eHealth Ventures and Venturing Ltd., as it readies for market launch Olive Diagnostics, developer of the world's first optical sensor for passive and seamless uranalysis ...
mehr
DEBIOPHARM ENCOURAGES BREAKTHROUGH CANCER RESEARCH IN JAPAN THROUGH ITS COMPETITIVE JCA MAUVERNAY AWARD
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research –Dr. Shumpei Ishikawa and ...
mehrMicreos secures EUR32 million for its endolysin-based platform as sustainable alternative to antibiotics
The Hague, The Netherlands (ots/PRNewswire) - Dutch biotechnology company Micreos announced it has secured another EUR32 million in funding to further develop its endolysin platform technology, based on targeted killing of only unwanted bacteria. This funding round will help Micreos accelerate its clinical ...
mehrHeart Experts Call For Millions To Benefit From Life-Saving Online Services As Telemedicine Rockets
Geneva (ots/PRNewswire) - - Cardiovascular disease (CVD) remains world's biggest killer, claiming 18.6 million lives per year On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health services to millions worldwide. COVID-19 has seen an explosion in telemedicine, with a 40%1 ...
mehrVidac Pharma Ltd Announces Wider Spectrum Authorization Of Its CTCL Phase 2 Clinical Trial
Rehovot, Israel (ots/PRNewswire) - BASED OF THE SATISFACTORY SAFETY DATA OF VIDAC VDA 1102 ON SELECTED PATIENTS VIDAC PHARMA RECEIVED AUTHORIZATION TO WIDEN THE SCOPE OF THE TRIAL TO CTCL WHOLE SPECTRUM OF CONDITIONS. "WE ARE VERY SATISFIED WITH THE RESULTS OF THE FIRST STEP WHICH ON TOP OF THE SAFETY RESULTS GRANTED TO OUR TRIAL A DOSE RANGING PROTOCOL AUTHORIZATION. ...
mehrHuadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China
Arnhem, Netherlands and Hangzhou, China (ots/PRNewswire) - Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine's medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative pulsatile ...
mehrNHS Deploys TytoCare's Telehealth Solution to 14 Trusts across the UK as part of Virtual Wards Project
New York (ots/PRNewswire) - Following a successful pilot with Bradford Teaching Hospitals, TytoCare to be utilised by 14 NHS organisations across Yorkshire and Humber in 26 projects to deliver high quality virtual care to patients TytoCare, the global health care industry's first all-in-one modular device and ...
mehr
Vorherige6789101112131415Nächste